Tag Archives: FDA Guidance

Conversation: Darshan Kulkarni on the FDA Draft Guidance

Last week Pixels & Pills' editor Briana Campbell had the pleasure of sitting down for a Skype chat (so the quality is a little lower than our normal, professional videos) with Dr. Darshan...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , | Leave a comment

In Light of FDA Draft Guidance? Keep Going

by Briana Campbell (@MsMatchGirl) By now, youve all had time to review the FDAs draft guidance on Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical...
Posted in Social Media | Tagged , , , , , , , , , , , , , | 8 Comments

Shoot First, Apologize Later: Why Pharma Needs to Proceed without Social Media Guidelines

by DJ Edgerton (@wiltonbound) Like Tom Petty sang, the waiting is the hardest part. But is it necessary for pharma to continue holding out for social media guidelines before implementing digital...
Posted in Social Media | Tagged , , , , , , , | 4 Comments

Revisited: Russ Ward on FDA Guidelines For Social Media

As we keep talking (and talking and talking) about and waiting (and waiting and waiting) for FDA Guidelines for social media usage, we thought it would be fun to visit this video, from nearly two...
Posted in Social Media | Tagged , , , , | Leave a comment

Fallout? Pharma & The Facebook Wall

by Briana Campbell (@MsMatchGirl) About a week and a half ago all the talk was about Facebook and its policy changes, disallowing pharmaceutical companies to turn off comments on their walls....
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , | 2 Comments

Damien Basile of Digital Somethings Talks About Regulation and Social Media

Damien Basile, co-founder of Digital Somethings talks about how companies can effectively use social media, even in heavy regulated...
Posted in Social Media | Tagged , , , , , , , , | 1 Comment